An Antiviral Formulation with DNA Gyrase and RNA Dependent RNA Polymerase Suppressive Features As an Adjunct Treatment for Coronaviral Infections
Published: 12 July 2021| Version 1 | DOI: 10.17632/c3c83ykmjx.1
Contributor:
Erdal Can AlkoclarDescription
A Combination of Protopanaxatriol Class Antiviral Glucopyranoside Analogues may serve as potent antiviral agents due to their RNA Dependent RNA Polymerase Suppressive and indirect Immunostimulant Action; Especially Protobioside Derivatives related Formulation.
Files
Categories
COVID-19